角膜血管缺陷是由于可溶性VEGF-1受体
Balamurali K Ambati1, Miho Nozaki, Nirbhai Singh
1Department of Ophthalmology, Medical College of Georgia & Augusta Veterans Affairs Medical Center, Augusta, Georgia 30907, USA.
Nature
|October 20, 2006
概括
可溶性VEGF受体-1 (sVEGFR-1) 通过捕获VEGF-A.通过捕获VEGF-A.保持角膜血管性. 其缺乏导致角膜血管化,而其管理恢复无血管性,突出其在视觉和血管治疗中的关键作用.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 发展生物学 发展生物学
背景情况:
- 角膜血管性对视力至关重要,并用于测试疗法.
- 尽管存在VEGF-A,但角膜无血管性的分子基础尚不清楚.
- VEGF-A是一种强大的血管生成刺激剂.
研究的目的:
- 阐明导致角膜无血管性的分子机制.
- 研究可溶性VEGF受体-1 (sVEGFR-1) 在维持角膜无血管性的作用.
主要方法:
- 研究了角膜中的sVEGFR-1表达.
- 使用中和抗体抑制内源性sVEGFR-1,RNA干扰和基因破坏.
- 向有角膜血管化病例的小鼠给予重组sVEGFR-1.
- 在不同的角膜血管化模式的各种物种中检查了sVEGFR-1表达.
主要成果:
- 角膜表达可溶性VEGF受体-1 (sVEGFR-1;也称为sflt-1).
- 抑制sVEGFR-1在小鼠中消除了角膜血管性.
- 在玉米1,Pax6+/-小鼠和无血病患者的角膜血管化与sflt-1缺乏相关.
- 重组sVEGFR-1在受影响的小鼠中恢复了角膜血管性.
- sVEGFR-1在各个物种中都存在,存在于非血管角膜 (海豚,大象,海豚,鱼),但不在血管化角膜 (海) 中.
结论:
- sVEGFR-1对于保持角膜无血管性至关重要.
- sVEGFR-1 作为一种内源的 VEGF-A 陷.
- 这些发现指导了对角膜用于血管新生调节器验证和治疗神经血管疾病的使用.
- sVEGFR-1 可能提供对角膜免疫特权的见解.
相关概念视频
01:10Mechanism of Angiogenesis
7.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.7K
01:24Regulation of Angiogenesis and Blood Supply
4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K